JAMES WELSH to Cost-Benefit Analysis
This is a "connection" page, showing publications JAMES WELSH has written about Cost-Benefit Analysis.
Connection Strength
0.159
-
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. J Geriatr Oncol. 2015 Jul; 6(4):324-31.
Score: 0.092
-
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases. Int J Radiat Oncol Biol Phys. 2022 12 01; 114(5):977-988.
Score: 0.037
-
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors. J Immunother Cancer. 2018 11 23; 6(1):128.
Score: 0.029